Cadonilimab
Product Specifications
CAS Number
2394841-59-7
Target
PD-1/PD-L1, Immunology/Inflammation related, COX, IL Receptor
Related Pathways
Neuroscience, Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint
Purity
0.95
Bioactivity
Cadonilimab (AK104) is a tetravalent PD-1/CTLA-4 bispecific humanised antibody that activates T cells by enhancing IL-2 and IFN-γ secretion while reducing pro-inflammatory cytokine secretion (e.g., IL-6, IL-8) . It offers low toxicity and high affinity, making it suitable for metastatic cervical, gastric, hepatic, and pulmonary cancers, pancreatic cancer, and oesophageal squamous cell carcinoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
